Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer.
Yongri QianXingzhe LiuYing FengXiaogang LiYanhua XuanPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)
Together, our findings suggest that Tenascin C is a prognostic marker for patients with prostate cancer and that its effects might be mediated via regulation of the glycolysis process of prostate cancer cells.